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Summary. The immunohistochemical expression of 
p53, p21, Rb, p16, cyclin D1, Ki67, cyclin A, cyclin B1, 
p27, bc12, bax, and bak proteins and the apoptotic index 
(AI) were investigated in 20 normal thymuses (8 adults, 
3 adolescents,  5 infants and 4 newborns).  The  
expressions of Rb, Ki67, cyclin A and cyclin B1 were 
overlapping, being high in the cortex with a tendency for 
decreased expression toward the medulla. Apoptotic 
cells were mainly detected in the cortex and the 
corticomedullary junction, rarely being present in 
Hassall's corpuscles. The mean values of Ki67, cyclin A, 
and cyclin B1 expression in thymuses were 77.2%, 
32.2% and 21.4% (newborns), 62.4%, 33.7% and 18.5% 
(infants), 56.9%, 23.4% and 18.9% (adolescents) and 
38.7%, 21.7% and 14.6% (adults), respectively. The 
mean values of AI in thymuses from newborns, infants, 
adolescents and adults were 1.4%, 2.9%, 2.7% and 
3.8%, respectively. This decrease in proliferation and 
increase in apoptosis may account for the process of 
thymic involution. P16 expression was widespread with 
most of Hassall's corpuscles being pl6-positive. P16- 
positive cells and Hassall's corpuscles increased with the 
increase in age, in keeping with the suggested role of 
p16 in cellular senescence. P27 expression was 
undetectable in subcapsular thymocytes with a tendency 
for increased expression toward the medulla. The 
expressions of Ki67, cyclin A and cyclin R1 were 
inversly related with that of p27, consistent with 
previous evidence that p27 concentration is reduced 
when the cell-cycle progresses. P21 and much less 
frequently p53 proteins were mainly detected in a part of 
the subcapsular cortical epithelial cells. These findings 
suggest that a) in thymocytes, the apoptotic pathway is 
mostly p53-independent and the function of p21 as a 
negative regulator of the cell cycle must be redundant to 
other negative regulators, such as p16 and p27 which 
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were abundantly detected in thymocytes and b) in some 
thymic epithelial cells, the p21 expression may be 
induced by p53, but in most of them seems to be p53- 
independent. Most of Hassall's corpuscles were p21- 
positive, consistent with previous evidence that these 
structures represent end stages of maturation of thymic 
medullary epithelium and that p21 protein is involved in 
the process of terminal differentiation. Cyclin D1 
positivity was found in some macrophages. Rc12 
expression was mainly seen in medullary thymocytes, 
reflecting the surviving thymocytes in this region. The 
expressions of Bax and bak were more widespread in 
both the medulla and cortex, suggesting that these 
proteins play a broader role than bc12 in the regulation of 
thymic apoptosis. 
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Introduction 
The regulation of cell cycle and proliferation in 
normal tissues relies on a complex molecular network 
involving cyclins, cyclin-dependent kinases (CDKs), 
cyclin-dependent kinase inhibitors (CDKls) (Gillet and 
Barnes, 1998) and two major growth-regulatory 
pathways: the p53 pathway and the Rbl  pathway 
(Liggett and Sidransky, 1998; Lopez-Saez et al., 1998; 
Mulligan and Jacks, 1998; Prives and Hall, 1999). 
Cyclins and CDKs form complexes acting at 
different phases of the cell cycle. Cyclins are divided 
into two main families (Gillet and Barnes, 1998). The 
G1 family includes cyclins C, D1-3 and E, which are 
important for the passage of cells through the G1 phase 
and their entry into the S-phase. The other family 
includes the mitotic cyclins A and B1-2. The activity of 
the cyclin-CDK complexes is negatively regulated by 
the CDKIs. There are two known families of CDKIs. 
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The INK4 family proteins (p16, p15, p18, and p19) 
inhibit cyclin D-CDK416 complexes, while the p21 
family proteins (p21, p27 and P57) inhibits all CDKs by 
binding to cyclin-CDK complexes. 
p53 protein may induce cell cycle arrest andtor 
apoptosis in response to different cellular stress (Prives 
and Hall, 1999). p53-dependent G1 arrest is mediated, at 
least in part, through p53-mediated induction of the 
CDKI p21. The activity and the stability of p53 protein 
is regulated via interactions with proteins such as mdm2 
which allows targeting of p53 to the ubiquitin-mediated 
proteolytic network. Phosphorylation of the Rb protein 
(pRb) results in release of the E2F transcription factor 
which is involved in the regulation of S-phase entry 
(Liggett and Sidransky, 1998; Mulligan and Jacks, 
1998). pRb phosphorylation is stimulated by cyclin- 
D/CDK4 complexes and inhibited by the the CDKl pl6. 
Moreover, there is recent evidence for a complex 
network linking the function of Rb and p53 genes via 
mdm2 directly (Hsieh et al., 1999). 
There is substantial evidence that the cell cycle and 
apoptosis are interconnected since cell cycle regulatory 
proteins may impinge on the apoptosis and vice versa 
(Brady et al., 1998; Gil-Gomez et al., 1998; Lundberg 
and Weinberg, 1999). Indeed, besides cell-cycle 
regulation, p53 is also involved in apoptosis through 
transcriptional regulation of redox-related genes, the 
formation of reactive oxygen species and the oxidative 
degradation of mitochondrial components (Polyak et al., 
1997). p53 may downregulate the expression of the 
antiapoptotic bc12 gene and upregulate the expression of 
the proapoptotic bax gene (Cox, 1997). In general, bc12 
and bcl-XI inhibit apoptosis, whereas bcl-xs, bax and bak 
promote apoptosis. Pro- and anti-apoptotic bc12 protein 
family members can heterodimerise and seemingly 
titrate one another's function, suggesting that their 
relative concentration may act as a rheostat for the cell 
suicide program (Adams and Cory, 1998; Evan and 
Littlewood, 1998). 
The human thymus is a lymphoepithelial organ in 
which T-cells develop during fetal life. After maturation 
and selection in the fetal microenvironment, T-cells 
emigrate to peripheral lymphoid tissues (lymph nodes, 
spleen and gut) and establish the peripheral T-cell 
repertoire (Haynes et al., 1998; Bodey et al., 1999). 
Although the thymus exhibits a profound involution 
during normal postnatal life, thymopoiesis with active T- 
cell receptor gene rearrangements continues normally 
within perivascular spaces into late life (Flores et al., 
1999). The multiple lymphoepithelial cellular events 
leading to thymic selection involve proteins regulating 
the apoptosis and the cell-cycle (Schreiber at al., 1996; 
Muller-Hermelink et al., 1997; Samms et al., 1999; 
Rosenheimer-Goudsmid et al., 2000) and previous 
studies reported the immunohistochemical expression of 
some of these proteins in normal thymuses which were 
mostly used as control tissues in pathological studies 
(Ohta et al., 1995; Onodera et al., 1996; Hirabayashi et 
al., 1997; Mateo et al., 1997; Sanchez-Beato et al., 1997; 
Engel e t  al., 1998; Penault-Llorca et al., 1998; 
Villuendas et al., 1998; Nielsen et al., 1999). The 
immunotopographical distribution of protein networks 
involved in cell-cycle andlor apoptosis regulation may 
be useful not only for the understanding of thymic 
histophysiology but a lso for the analysis of the 
histogenetic classification of thymic epithelia1 tumours 
(Marx and Muller-Hermelink, 1999, 2000). In this 
respect, we have previously observed that bc12 is 
expressed in normal medullary epithelium and medullary 
thymomas while p53 is expressed in normal cortical 
epithelium and cortical and predominantly cortical 
thymomas (Stefanaki et al., 1997). 
Prompted by the above data and since there is 
paucity of multiparametric,  combined immuno- 
histological information regarding cell cycle and 
apoptosis in normal thymus, we have investigated the 
immunotopography of p53, p21, Rb, p16, cyclin D1, 
p27, Ki67, cyclin A, cyclin B1, bc12, bax and bak 
proteins as well as the distribution of apoptotic cells 
using the TdT (terminal deoxynucleotidyl-transferase)- 
mediated in-situ labelling (TUNEL) method and 
conventional histology in 20 morphologically normal 
thymuses from adults,  adolescents,  infants and 
newborns. The  aim was to determine the 
immunotopography of proteins involved in a) the p53 
and Rbl growth control pathways, b) the proliferation, 
and c) the apoptosis in relation with age. 
Materials and methods 
Material 
Twenty thymuses from 8 adults, 3 adolescents, 5 
infants and 4 newborns removed during surgery for 
reasons other than thymic pathology were retrieved from 
the files of the Departments of Pathology of Agia Sophia 
Childrens'  Hospital of Athens and Evangelismos 
Hospital of Athens. None of the individuals had 
autoimmune disease. 
lmmunohistochemistry 
Immunostainings were performed on formalin-fixed, 
paraffin-embedded tissue sections by the alkaline- 
phosphataselanti-alkaline phospatase (APAAP) or the 
Streptavidin-Biotin Peroxidase labeled (LSAB) 
procedures. A pretreatment with microwave oven 
heating was performed as has been previously described 
(Kanavaros et al., 2000). Monoclonal antibodies directed 
against p53 protein (DO-7;  Dako SA, Glostrup, 
Denmark, dilution 1:50), p2lIwafl  protein (EA-10; 
Calbiochem, dilution 1:50), Rb protein (Rbl;  Dako, 
dilution 1:20), proliferation-associated nuclear antigen 
Ki67 (MIB-1; Immunotech, Marseille, France, dilution 
1:20), p16 (F-12; Santa Cruz Biotechnology, California 
USA, dilution 1:100), p27 (F-8; Santa Cruz, dilution 
1:50), cyclin D1 (DSc-6; Novocastra, dilution 1:20) 
cyclin A (6E6; Novocastra, dilution 1:10), cyclin B1 
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(7A9; Novocastra, dilution 1:lO) and bc12 (Dako 124, 
dilution 150)  were applied. In addition, the polyclonal 
antibodies bax (Dako, code A3533, dilution 1:500) and 
bak (Dako, code A3538, dilution 1:250) were also 
applied. Double s taining using cytokeratin or 
CD451LCA with p53, p21 and Rb, respectively was 
performed i n  some cases as has been described 
previously (Petit et al., 2001). Positive control slides 
were included in all cases. They consisted of normal 
thymuses, thymomas and lymphomas from our previous 
studies known to be positive for p53, p21, or cyclin D1 
(Stefanaki et al., 1997; Kanavaros et al. ,  2000; 
Kanavaros et al., 2001). For Rb, p16, bc12, bax, bak, 
p27, cyclin A, cyclin B1 and Ki67 internal positive 
control was required. The immunostaining for cyclin A, 
cyclin B1 and Ki67 was interpreted by four independent 
observers (P.K., K.S., D.P., D.A.). For evaluation of 
imrnunostaining, a continuous score system was adopted 
by using the x40 objective lense and by counting the 
immunopositive cells in 10 randomly selected fields. 
The number of immunopositive cells was divided by the 
total number of the counted cells and the expression was 
defined as the percentage of positive cells in the the total 
number of the cells counted. Then, the groups of 
positivity were determined using cut-off levels as 
follows: less than 5% (+I-); 5 to 25% (+); 25% to 50% 
( t t ) ;  and more than 50% ( t t t ) .  
The TdT (terminal deoxynucleotidyl-transferase)- 
mediated in-situ labelling technique (TUNEL) (Apotag 
kit, Oncor, Calbiochem) was carried out as previously 
described (Czader et al., 1996). Internal positive control 
was required and negative controls (sections without 
TdT) were included in every staining. The results were 
interpreted as previously described (Kanavaros et al., 
2001) by three observers (P.K., M.B., D.R). 
Morphologically intact TUNEL-positive cells and 
apoptotic cells in heamotoxylin-eosin stained slides 
(defined as cells with condensed, hyperchromatic, ring- 
like, crescentic or beaded chromatin and often 
surrounded by a clear halo) were considered as positive 
Table 
cyclin 
1. Expression of p53, p21, Rb, p16, Ki67, p27, bc12, bax, bak, 
A and cyclin B1 proteins in thyrnocytes. 
CORTICAL MEDULLARY 
and are referred to as apoptotic cells. Necrotic areas 
were excluded. The number of apoptotic cells was 
recorded by using the x40 objective and by counting the 
apoptotic cel ls  in 10  randomly selected fields, 
corresponding to a total of 2000 to 3000 cells. The 
apoptotic index (AI) was determined as the number of 
apoptotic cells expressed as a percentage of the total 
number of counted cells. 
Statistical analysis 
Chi-square test was performed for categorical 
variables. Pearson's and Spearman's  correlation 
coefficients were used for the assessment of correlation 
between continuous variables. The  results were 
considered as statistically significant with p<0.05. The 
statistical analysis was performed using the program 
SPSS 8 for Windows. 
Results 
Analysis of immunotopography 
The immunohistochemical results are summarised in 
Tables 1 and 2. There was a rather overlapping 
immunotopographical distribution of the Rb, Ki67, 
cyclin A and cyclin B1 proteins. The expressions of Rb 
and Ki67, cyclin A and cyclin B1 proteins were high in 
the cortex, mainly in thymocytes but also in epithelial 
cells, with a tendency for decreased expression toward 
the medulla (Figs. 1-3). Statistically significant positive 
correlation was found between RblKi67, cyclin A/Ki67 
and cyclin Bl lKi67  expression in each age group 
separately and in all groups analysed together (in all 
p<0.01). p16 expression was widespread in both cortex 
and medulla with most of Hassall's corpuscles being 
pl6-positive. pl6-positive cells and Hassall's corpuscles 
increased with the increase in age. p27 expression was 
undetectable in subcapsular thymocytes of the outer 
cortex but an increase in the frequency of positive cells 
was observed parallel to the progression toward the 
medulla. The medullary thymocytes showed generalized 
Table 2. Expression of p53, p21, Rb, p16, Ki67, p27, bc12, bax, bak, 
cyclin A and cyclin B1 proteins in thymic epithelial cells. 
SUBCAPSULAR CORTICAL MEDULLARY HASSAL 
CORPUSCLES 
P53 
P21 
R b 
p1 6 
Ki67 
P27 
Bc12 
Bax 
Bak 
Cyclin A 
Cyclin B1 
P53 + 
P21 ++ 
R b ++ 
P1 6 ++ 
Ki67 + 
P27 ++ 
Bc12 
Bax + 
Bak ++ 
Cyclin A + 
Cyclin B1 + 
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p27 expression. Cortical and medullary epithelial cells as cyclin B1 proleins. p21 and much less frequently, p53- 
well as Hassall's corpuscles were p27 positive. There positive epithelial cells (Fig. 4) were detected mainly in 
was a rather mutually exclusive immunotopographical the cortex, particularly i n  the subcapsular region, 
distribution of the p27 with the Ki67, cyclin A and whereas these proteins were undetectable in thymocytes. 
Fig. 1. Ki67 
immunoexpression in the 
normal thymus. X 50 
Fig. 2. Cyclin A 
imrnunoexpres~ion in 
the normal thymus. 
X 250 
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Although most medullary epithelia1 cells were p21- expression was mainly seen in the medulla and mostly in 
negative, Hassall's corpuscles were p21-positive. Cyclin thymocytes. The expressions of Bax and bak were more 
D1 positivity was observed in some macrophages. Bc12 widespread, in both the medulla and cortex. Bak showed 
Fig. 3. Cyclin B1 
immunoexpression i 
the normal thymus. 
X 250 
Fig. 4. Double p53 
(red staining: arrows) 
and CD45 (brown 
staining) 
immunoexpres~ion in 
the cortex of normal 
thymus. X 400 
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a tendency to be expressed more frequently in epithelia1 
cells than in thymocytes. Hassall's corpuscles were 
positive for bak but negative for bc12 and bax. In two 
thymuses from adults lymphoid follicles were observed. 
Germinal centers showed high Rb, p16, Ki67, bax and 
bak expression whereas that of bc12, p27, p21 and p53 
was very low to absent. 
Apoptotic index and relation with the proliferation profile 
The TUNEL method and the morphological 
evaluation revealed that apoptotic cells were mainly 
scattered throughout the cortex and in the 
corticomedullary junction. Apoptotic cells were rarely 
detected in Hassall's corpuscles. The mean values of 
Ki67, cyclin A, and cyclin B1 expression in thymuses 
were 77.2%, 32.2% and 21.4% (newborns), 62.4%, 
33.7% and 18.5% (infants), 56.9%, 23.4% and 18.9% 
(adolescents) and 38.7%, 21.7% and 14.6% (adults), 
respectively. The mean values of A1 in thymuses from 
newborns, infants, adolescents and adults were 1.4%, 
2.9%, 2.7% and 3.8%, respectively. Statistically 
significant positive correlation (pc0.01) was found 
between AI and Ki67 expression in each age group. 
Discussion 
In the present study, the analysis of the RbIpl6 
immunotopography in combination with the 
proliferation profile showed overlapping immuno- 
topographical distribution of the Rb and Ki67, cyclin A 
and cyclin B1 proteins, mainly localised in the cortex. In 
this region, p16 expression was also high. This tendency 
for parallel Rb/Ki67 and p16lKi67 expression has 
previously been described in normal lymph nodes 
(Martinez et al., 1993; Villuendas et al., 1997) and 
indicates that higher levels of Rb and p16 are present in 
those compartments where cell proliferation is increased, 
reflecting the roles of Rb and p16 in controlling cell- 
cycle (Gillet and Barnes, 1998). In addition, high Rb 
expression may also represent an attempt to inhibit the 
high rate of apoptosis which occurs in the cortical 
thymocytes, in view of the evidence that Rb protein may 
function not only as a negative regulator of proliferation 
but also of apoptosis (Haas-Kogan, 1995). On the other 
hand, the expression of p16 was also high in the medulla 
wherein Ki67, cyclin A and cyclin B1 expression was 
decreased. This suggests, in keeping with a previous 
study reporting only on expression of p16 in thymus 
from newborns (Nielsen et al., 1999), that the expression 
of p16 does not always correlate with cell proliferation. 
p16 expression was widespread in both cortex and 
medulla with most of Hassall's corpuscles being p16- 
positive. pl6-positive cells and Hassall's corpuscles 
increased with the increase in age. This is in keeping 
with previous immunohistological results on newborn 
thymic tissues (Nielsen et al., 1999), showing restriction 
of p16 staining to Hassall's corpuscles and scattered 
epithelial and lymphoid cells of the thymus, the only 
organ comitted to early cellular senescence (Bodey et al., 
1997) and in vitro studies showing that p16 
accumulation is associated with cellular senescence in 
human transformed uroepithelial cells and in malignant 
glioma cells (Reznikoff et al., 1996; Uhrbom et al., 
1997). Taken together, the above data are consistent with 
the hypothesis that p16 serves a checkpoint function 
during cellular senescence. 
In the present study, the analysis of the p53Ip21 
immunotopography showed that p21 and p53 proteins 
were undetectable in thymocytes but p21 and, much less 
frequently, p53 expression was mainly detected in a part 
of the subcapsular cortical epithelial cells. These 
findings suggest that a) in thymocytes, the apoptotic 
pathway is mostly p53-independent in keeping with 
previous in vitro data regarding the thymic-epithelia1 
cell-induced apoptosis of CD4+/CD8+ thymocytes 
(Rosenheimer-Goudsmid et al., 2000) and the function 
of p21 as negative regulator of the cell cycle must be 
redundant to other negative regulators, such as p16 and 
p27 which were detected in a large number of 
thymocytes, and b) in some thymic epithelial cells, p21 
expression may be induced by p53 after cellular stress or 
DNA damage (Prives and Hall, 1999) and represents an 
inhibitory response to the cell cycle progression. 
However, in most of these cells, p21 expression seems to 
be p53-independent (Cox, 1997). In this respect, i t  is 
also noteworthy that a proportion of cortical epithelial 
cells express Rb protein which was reported to play an 
essential role in cell cycle arrest after DNA damage 
(Harrington et al., 1998). On the other hand, most of 
Hassall's corpuscles were found to express p21 protein. 
This is consistent with previous evidence that Hassall's 
corpuscles represent end stages of maturation of thymic 
medullary epithelium (Bodey et al., 1997) and that p21 
protein is involved in the process of terminal 
differentiation (Cox, 1997). 
In the present study, the analysis of the proliferation 
profile showed that the mean values of Ki67, cyclin A, 
and cyclin B1 expression in thymuses were 77.2%, 
32.2% and 21.4% (newborns), 62.4%, 33.7% and 18.5% 
(infants), 56.9%, 23.4% and 18.9% (adolescents) and 
38.7%, 21.7% and 14.6% (adults), respectively. The 
mean values of AI in thymuses from newborns, infants, 
adolescents and adults were 1.4%, 2.9%, 2.7% and 
3.8%, respectively. This decrease in proliferation and 
increase in apoptosis may account for the process of 
thymic involution. 
In the present study, the analysis of apoptosis-related 
proteins of the Bc12 family showed Bc12 expression 
mainly in the medulla and mostly in thymocytes, 
reflecting the surviving thymocytes in this region. The 
expressions of Bax and bak were more widespread, in 
both the medulla and cortex suggesting that these 
proteins play a broader role than bc12 in the regulation of 
thymic apoptosis. Interestingly, Hassall's corpuscles 
showed positivity for bak but not for bc12 and bax. Since 
bak promotes apoptosis, our findings are in line with 
previous evidence that Hassall's corpuscles are 
considered to be the only medullary site of thymocyte 
apoptosis (Douek and Altmann, 2000). This was also 
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confirmed in our study by the detection of apoptotic 
cells in some Hassall's corpuscles. 
There is substantial evidence that p27 is involved in 
cell cycle arrest and in the regulation of apoptosis (Lloyd 
et al., 1999). In the present study, the expression of p27 
was rather alternative to the expression of Ki67, cyclin A 
and cyclin B1 proteins, in keeping with previous 
p27lKi67 results on normal thymus (Sanchez-Beato et 
al., 1997). This is consistent with evidence that p27 
concentration is reduced when cell-cycle progresses 
upon suitable mitogenic stimulation (Lloyd et al., 1999). 
The reduced p27 expression may permit sequential 
phosphorylation (inactivation) of Rb by the cyclin 
D/CDK4,6 and cyclinE-CDK2 complexes resulting in 
release of E2F from Rb in order to activate S-phase entry 
(Mulligan and Jacks, 1998) or  may abrogate  the 
association between cyclinE-CDK2 and p107-E2F 
complexes resulting in transcriptional activation of the 
mitotic cyclin A (Zerfass-Thome et al., 1997). 
Besides its role in cell cycle, p27 has also been 
implicated in the regulation of apoptosis (Lloyd et al., 
1999). Indeed, a recent study has provided evidence that 
thymocytes undergoing apoptosis degrade p27 and 
upregulate CDK2 activity, this process being regulated 
by p53, bax and bc12 (Gil-Gomez et al., 1998). These 
findings are in keeping with our immunohistological 
observation that p27 expression increases from the 
cortex to the medulla in parallel with the decreased 
frequency of apoptotic cells, suggesting a role for p27 in 
protecting thymocytes from apoptosis. 
A potential explanation may be related to recent in 
vitro results showing that p27 may protect mesangial 
cells and fibroblasts from apoptosis by costraining the 
CDK2 activity (Hiromura et al., 1999), which was 
shown to be essential for the apoptotic pathway used in 
negative thymic selection (Williams et al., 2000). 
Another explanation may be related to the Fas (CD95)- 
mediated cell death in thymus (Castro et al., 1996; 
Hersberger et al., 1998). There is evidence that Fas- 
mediated cell death occurs only during late G1 or G1/S 
phase transition whereas cells arrested in G1 are resistant 
to Fas-mediated apoptosis (Komada et al., 1995). 
Therefore, i t  could be suggested that p27 expression 
resulting in G1 arrest might render thymocytes resistant 
to Fas-mediated apoptosis. However, recent findings do 
not support this hypothesis since the CD95 pathway does 
not require CDK2 activation to induce cell  death 
indicating that the biochemical pathway used in the 
CD95-mediated cell death plays no role in negative 
selection (Williams et al., 2000). 
In summary, the present study reports the detailed 
immunotopographical distribution of proteins playing 
central roles in the regulation of the cell cycle and 
apoptosis in the human thymuses from various age- 
groups and provides in-situ evidence that the process of 
thymic involution may be related to the decrease of 
proliferation and increase of apoptosis. 
Acknowledegments. The authors are grateful to A. Christodoulou for her 
References 
Adams J.M. and Cory S. (1998). The BCL-2 family proteins. Arbiters of 
cell survival. Science 281, 1322-1326 
Bodey B. and Kaiser H.E. (1997). Development of Hassal's bodies of 
the thymus in humans and other vertebrates (especially mammals) 
under physiological and pathological conditions: immunohisto- 
chemical, electronmicroscopic and in vitro observations. In Vivo 11, 
61 -85 
Bodey B., Bodey B. Jr.. Siegel S.E. and Kaiser H.E. (1999). Molecular 
biological ontogenesis of the thymic reticule-epithelia1 cell network 
during the organization of the microenvironment. In Vivo 13, 267- 
294 
Brady H.J., Gil-Gomez G.. Kirberg J. and Berns A. (1998). Bax alpha 
perturbs T cell development and affects cell cycle entry of T cells. 
EMBO J. 15, 6991 -7001. 
Broome H.E., Dargan C.M., Krajewski S. and Reed J.C. (1995). 
Expression of Bcl-2, Bcl-X and Bax after T-cell activation and IL-2 
withdrawal. J. Immunol. 155, 231 1-2317 
Castro J.E., Listman J.A., Jacobson B.A.. Wang Y., Lopez P.A., Ju S., 
Finn P.W. and Perkins D.L. (1996). Fas modulation of apoptosis 
during negative selection of thymocytes. Immunity 5, 617-627. 
Cox L.S. (1997). Multiple pathways control cell growth and 
transformation: overlapping and independent activities of p53 and 
p21. J. Pathol. 183, 134-140. 
Czader M,, Mazur J., Pettersson M,, Liliemark J., Stromberg M,, 
Christennson B., Tribukait B., Auer G., Ost A. and Porwit A. (1996). 
Prognostic significance of proliferative and apoptotic fractions in low 
grade follicle center cell-derived non-Hodgkin's lymphomas. Cancer 
77, 11 80-1 188. 
Douek D.C. and Altmann D.M. (2000). T-cell apoptosis and differential 
human leucocyte antigen class II expression in human thymus. 
Immunology 99, 249-256. 
Engel P,, Francis D. and Graem N. (1998). Expression of bcl-2 in fetal 
thymus, thymomas and thymic carcinomas. Association with p53 
expression and review of the literature. APMlS 106, 449-455 
Evan G. and Littlewood T. (1998). A matter of life and cell death. 
Science 281, 131 7-1 322 
Flores K.G., Li J., Sempowski G.D, Haynes B.F. and Hale S. (1999). 
Analysis of the human thymic perivascular space during aging. J. 
Clin. Invest. 104. 1031-1 039 
Gil-Gomez G., Berns A. and Brady H.J. (1998). A link between cell cycle 
and cell death: Bax and Bcl-2 modulate Cdk2 activation during 
thymocyte apoptosis. EMBO J. 17, 7209-7218. 
Gillet C.E. and Barnes D.M. (1998). Cell cycle. J. Clin. Pathol. (Mol 
Pathol.) 51, 310-316. 
Haas-Kogan D.A., Kogan S.C., Levi D., Dazin P., Tang A., Fung Y.K. 
and Israel M.A. (1995). Inhibition of apoptosis by the retinoblastoma 
gene product. EMBO J. 14, 461-472. 
Harrington E.A.. Bruce J.L., Harlow E. and Dyson N. (1998). pRb plays 
an essential role in cell cycle arrr~st induced by DNA damage. Proc. 
Natl. Acad. Sci. USA 95, 11 945-1 1950 
Haynes B.F. and Hale L.P. (1998). The human thymus. A chimeric 
organ comprised of central and peripheral lymphoid components. 
Immunol. Res. 18, 175-1 92. 
Hershberger P.A.. He H. and McCarthy S.A. (1998). In vitro thymocyte 
maturation is associated with reduced cellular susceptibility to Fas- 
mediated apoptosis. Cell Immunol. 185, 134-1 45. 
Hiromura K., Pippin J.W., Fero M.L., Roberts J.M. and Shankland S.J. 
excellent technical assistance. (1999). Modulation of apoptosis by the cyclin-dependent kinase 
Cell cycle proteins and apoptosis in normal thymus 
inhibitor p27 (Kipl). J. Clin. Invest. 103. 597-604. 
Hsieh J.K.. Chan F.S.G., O'Connor D.J., Mittnacht S., Zhong S., and Lu 
X. (1999). Rb regulates the stability and the apoptotic function of 
p53 via mdm2. Mol. Cell 3. 181 -1 93. 
Hirabayashi H.. Fujii Y., Sakagushi M,, Tanaka H., Yoon H.E., Komoto 
Y., lnoue M,, Miyoshi S. and Matsuda H. (1997). p161INK4, pRB, 
p53 and cyclin D1 expression and hypermethylation of CDKN2 gene 
in thymoma and thymic carcinoma. Int. J. Cancer 73, 639-44. 
Kanavaros P., Stefanaki K., Vlachonikolis J., Eliopoulos G., Kakolyris S., 
Rontogianni D., Gorgoulis V. and Georgoulias V. (2000). Expression 
of p53, p2llwaf-l, bcl-2, bax, Rb and Ki-67 proteins in Hodgkin's 
lymphomas. Histol. Histopathol. 15, 445-453. 
Kanavaros P,, Bai M,, Stefanaki K., Poussias G., Rontogianni D., Zioga 
E., Gorgoulis V. and Agnantis N.J. (2001). lmmunohistochemical 
expression of p53, mdm2, p21lwaf-l, Rb, p16, Ki-67, cyclin A and 
cyclin B1 proteins and apoptotic index in T-cell lymphomas. Histol 
Histopathol. 16, 377-386. 
Komada Y., Zhou Y.W. and Zhang X.L. (1995). Fas receptor (CD95)- 
mediated apoptosis is induced in leukemic cells entering G I B  
compartment of the cell cycle. Blood 86, 3848-3860 
Liggett W., and Sidransky D. (1 998). Role of the p1 6 tumor suppressor 
gene in cancer. J. Clin. Oncol. 16, 1 197-1 206. 
Lloyd R.V., Erickson L.A., Jin L.. Kulig E., Qian X., Cheville J.C. and 
Scheithauer B.W. (1999). P27lKIP1: a multifunctional cyclin- 
dependent kinase inhibitor with prognostic significance in human 
cancers. Am. J. Pathol. 154, 313-323. 
Lopez-Saez J.F., de la Torre C.. Pincheira J. and Gimenez-Marlin G. 
(1998). Cell proliferation and cancer. Histol. Histopathol. 13, 1197- 
1214. 
Lundberg A.S. and Weinberg R.A. (1999). Control of the cell-cycle and 
apoptosis. Eur. J. Cancer 35, 1886-1894 
Martinez J.C., Piris M.A., Sanchez-Beato M., Villuendas R., Orradre 
J.L., Algara P.. Sanchez-Verde L. and Martinez P. (1993). 
Retinoblastoma (Rb) gene product expression in lymphomas. 
Correlation with Ki67 growth fraction. J. Pathol. 169, 405-41 2. 
Marx A. and Muller-Hermelink H.K. (1999). From basic immunology to 
the upcoming WHO-classification of tumors of the thymus. The 
second conference on Biological and Clinical Aspects of thymic 
epithelial tumors and related recent developments. Pathol. Res. 
Pract. 195, 51 5-533. 
Marx A. and Muller-Hermelink H.K. (2000). Towards a histogenetic 
classification of thymic epithelial tumours. Histopathology 36, 466- 
469. 
Mateo MS., Saez A.I., Sanchez-Beato M., Garcia P,, Sanchez-Verde 
L., Martinez J.C., Orradre J.L. and Piris M.A. (1997). Expression of 
p2I/WAFl/CIPl in fetal and adult tissues: s~multaneous analysis 
with Ki67 and p53. J. Clin. Pathol. 50, 645-653. 
Mulligan G. and Jacks T. (1998). The retinoblastoma gene family: 
cousins with overlapping interests. TIG 14, 223-229. 
Muller-Hermelink H.K., Wilisch A., Schultz A. and Marx A. (1997). 
Characterization of the human thymic microenvironment: 
lymphoepithelial interaction in normal thymus and thymoma. Arch. 
Histol. Cytol. 60, 9-28 
Nielsen G.P., Stemmer-Rachamimov A.O., Shaw J., Roy J.E., Koh J. 
and Louis D.N. (1999). lmmunohistochemical survey of p161NK4A 
expression in normal human adult and infant tissues. Lab. Invest. 
79, 1137-1 143. 
Ohta K., lwai K., Kasahara Y., Taniguchi N., Krajewski S., Reed J.C. 
and Miyawaki T. (1995). lmmunoblot analysis of cellular expression 
of Bcl-2 family proteins, bcl-2, Bax, Bcl-X and Mcl- l ,  in human 
peripheral blood and lymphoid tissues. Int. Immunol. 11, 181 7-1825. 
Onodera J., Nakamura S., Nagano I., Tobita M,, Yoshioka M., Takeda 
A., Oouchi M. and ltoyama Y. (1996). Upregulation of Bcl-2 protein 
in the myasthenic thymus. Ann. Neurol. 39, 521-528. 
Penault-Llorca F., Bouabdallah R., Devilard E., Charton-Bain M.C., 
Hassoun J., Birg F, and Herri L. (1998). Analysis of BAX expression 
in human tissues using the anti-BAX, 4F11 monoclonal antibody on 
paraffin sections. Pathol. Res. Pract. 194, 457-464. 
Petit B., Leroy K., Kanavaros P.. Boulland M.L., Druet-Cabanac M., 
Haioun C., Bordessoule D. and Gaulard P. (2001). Expression of 
p53 protein in T and NK-cell lymphomas is associated with some 
clinicopathologic entities but rarely related to p53 mutations. Hum. 
Pathol. 32, 196-204 
Polyak K., Xia Y., Zweler J.L., Kinzler K.W., and Vogelstein B. (1997). A 
model for p53-induced apoptosis. Nature 389.300-305. 
Prives C. and Hall P. (1999). The p53 pathway. J. Pathol. 187, 112-126. 
Reznifoff C.A., Yeager T.R., Belair C.D.. Savelieva E., Puthenveettil 
J.A., and Stadler W.M. (1996). Elevated p16 at senescence and loss 
of p16 at immortalization in human papilloma virus 16E6 but not E7. 
transformed human uroepithelial cells. Cancer Res. 56, 2886-2890. 
Rosenheimer-Goudsmid N., Haupt Y., Yefenof E., Zilberman Y .  and 
Guy R. (2000). P53 and thymic 'death by neglect': thymic epithelial 
cell- induced apoptosis of CD4+ICD8+ thymocytes is p53- 
independent. Cell Death Differ. 7, 241-249. 
Samms M,, Philip D., Emanus F., Osuji O., Pezzano M, and Guyden 
J.C. (1999). Lysosomal-mediated degradation of apoptotic 
thymocytes within thymic nurse cells. Cell Immunol. 197, 108- 
115. 
Sanchez-Beato M,, Saez A.I., Martinez-Montero J.C., Sol-Mateo M., 
Sanchez-Verde L., Villuendas R., Troncone G, and Piris M.A. 
(1997). Cyclin-dependent kinase inhibitor p27/KIP1 in lymphoid 
tissue. P27/KIP1 expression is inversely proportional to the 
proliferative index. Am. J. Pathol. 151, 151-160. 
Schreiber L., Sharabi Y., Schwartz D., Goldfinger N., Brodie C., Rotter 
V. and Shoham J. (1996). Induction of apoptosis and p53 
expression in immature thymocytes by direct interaction with thymic 
epithelial cells. Scand. J. Immunol. 44, 314-22. 
Stefanaki K., Rontogianni D., Kouvidou C., Bolioti S., Delides G.. 
Sotsiou F. and Kanavaros P. (1997). lmmunohistochemical 
expression of bc12, p53, mdm2 and p2lIwaf-l proteins in thymomas. 
Histopathology 30, 549-555. 
Uhrbom L., Nister M. and Wastermark B. (1997). lnduction of 
senescence in human malignant glioma cells by p16IINK4A. 
Oncogene 15,505-51 4. 
Villuendas R., Sanchez-Beato M., Martinez J.C., Saez A., Martinez- 
Delgado B., Garcia J., Sol-Mateo M,. Sanchez-Verde L., Beniter J.. 
Martinez P. and Piris M. (1998). Loss of p161INK4A protein 
expression in non-Hodgkin's lymphomas is a frequent finding 
associated with tumor progression. Am. J. Pathol. 153, 887-897. 
Williams 0.. Gil-Gomez G.. Norton T., Kioussis D. and Brady H.J.M. 
(2000). Activation of Cdk2 is a requirement for antigen-mediated 
thymic negative selection. Eur. J. Immunol. 30, 709-713. 
Zerfass-Thome K., Schultze A., Zwerschkew W., Vogt B., Helin K., 
Bartek J., Henglein B. and Jansen-Durr P. (2000). P27lKIP1 blocks 
cyclin E-dependent transactivation of cyclin A gene expression. Mol. 
Cell. Biol. 17, 407-41 5. 
Accepted May 21,2001 
